Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI)

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 23, 2016

Primary Completion Date

June 6, 2019

Study Completion Date

June 6, 2019

Conditions
Radiation Necrosis
Interventions
DRUG

25% Mannitol

"Route of administration:~In this study, the first step of the treatment will be performing osmotic blood-brain-barrier disruption with administration of intra-arterial 25% Mannitol into the appropriate cervical artery."

DRUG

Low-dose Intra-arterial Bevacizumab

"Route of administration:~In this study, the second step of the treatment will be administering intra-arterial targeted bevacizumab into the appropriate cervical artery."

Trial Locations (2)

40242

Norton Brownsboro Hospital, Louisville

40536

University of Kentucky Medical Center, Lexington

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Kentucky

OTHER

lead

Norton Healthcare

OTHER